Skip to main content
Erschienen in: Archives of Dermatological Research 2/2017

17.12.2016 | Original Paper

Immunolocalization of substance P and NK-1 receptor in vascular anomalies

verfasst von: Alejandro Ortiz-Prieto, José Bernabeu-Wittel, Teresa Zulueta-Dorado, Ana I. Lorente-Lavirgen, Miguel Muñoz

Erschienen in: Archives of Dermatological Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The peptide substance P (SP) shows a widespread distribution in both the central and peripheral nervous systems, but it is also ubiquitous in the human body. After binding to the neurokinin-1 (NK-1) receptor, SP regulates tumoral angiogenesis and proliferation. Thus, knowledge of this system is the key for a better understanding and, hence, a better management of many human diseases, including vascular anomalies (VA). This study aims to examine the expression and localization of both SP and the NK-1 receptor in different vascular anomalies using an immunohistochemical technique. Our results demonstrated predominantly nuclear localization of SP in venous malformations and in one haemangioma sample, in contrast with cytoplasmic expression in capillary malformations and rapidly involuting congenital hemangioma (RICH). NK-1 receptor showed a cytoplasmic localization in all VA. In summary, all these findings demonstrate that SP and NK-1 receptor are expressed in VA, with different expression patterns depending on the nature of the anomaly, suggesting that they could play an important role in the pathogenesis of VA.
Literatur
1.
Zurück zum Zitat Aliakbari J, Sreedharan SP, Turck CW et al (1987) Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun 148:1440–1445CrossRefPubMed Aliakbari J, Sreedharan SP, Turck CW et al (1987) Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun 148:1440–1445CrossRefPubMed
2.
Zurück zum Zitat Berger M, Neth O, Ilmer M et al (2014) Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol 60:985–994CrossRefPubMed Berger M, Neth O, Ilmer M et al (2014) Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol 60:985–994CrossRefPubMed
3.
Zurück zum Zitat Bielenberg DR, Bucana CD, Sanchez R et al (1999) Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 14:401–408PubMed Bielenberg DR, Bucana CD, Sanchez R et al (1999) Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 14:401–408PubMed
4.
Zurück zum Zitat Böckle BC, Sölder E, Kind S et al (2008) DC-SIGN + CD163 + Macrophages Expressing Hyaluronan Receptor LYVE-1 Are Located within Chorion Villi of the Placenta. Placenta 29:187–192CrossRefPubMed Böckle BC, Sölder E, Kind S et al (2008) DC-SIGN + CD163 + Macrophages Expressing Hyaluronan Receptor LYVE-1 Are Located within Chorion Villi of the Placenta. Placenta 29:187–192CrossRefPubMed
6.
Zurück zum Zitat Brener S, González-Moles MA, Tostes D et al (2009) A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer Res 29:2323–2329PubMed Brener S, González-Moles MA, Tostes D et al (2009) A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer Res 29:2323–2329PubMed
7.
Zurück zum Zitat Castellani ML, Galzio RJ, Felaco P et al (2010) VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents 24(3):229–237PubMed Castellani ML, Galzio RJ, Felaco P et al (2010) VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents 24(3):229–237PubMed
8.
Zurück zum Zitat Chiwakata C, Brackmann B, Hunt N et al (1991) Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis. Endocrinology 128:2441–2448CrossRefPubMed Chiwakata C, Brackmann B, Hunt N et al (1991) Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis. Endocrinology 128:2441–2448CrossRefPubMed
9.
Zurück zum Zitat Demir R, Seval Y, Huppertz B (2007) Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 109:257–265CrossRefPubMed Demir R, Seval Y, Huppertz B (2007) Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 109:257–265CrossRefPubMed
10.
Zurück zum Zitat Esteban F, González-Moles MA, Castro D et al (2009) Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. Histopathology 54:258–260CrossRefPubMed Esteban F, González-Moles MA, Castro D et al (2009) Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. Histopathology 54:258–260CrossRefPubMed
11.
Zurück zum Zitat Garzon MC, Huang JT, Enjolras O et al (2007) Vascular malformations: Part II: associated syndromes. J Am Acad Dermatol 56:541–564CrossRefPubMed Garzon MC, Huang JT, Enjolras O et al (2007) Vascular malformations: Part II: associated syndromes. J Am Acad Dermatol 56:541–564CrossRefPubMed
12.
Zurück zum Zitat González-Moles MA, Mosqueda-Taylor A, Esteban F et al (2008) Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol 44:1127–1133CrossRefPubMed González-Moles MA, Mosqueda-Taylor A, Esteban F et al (2008) Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol 44:1127–1133CrossRefPubMed
13.
Zurück zum Zitat Guha S, Eibl G, Kisfalvi K et al (2005) Broad-spectrum G protein–coupled receptor antagonist, [D-Arg1, DTrp5,7,9, Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res 65:2738–2745CrossRefPubMed Guha S, Eibl G, Kisfalvi K et al (2005) Broad-spectrum G protein–coupled receptor antagonist, [D-Arg1, DTrp5,7,9, Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res 65:2738–2745CrossRefPubMed
14.
Zurück zum Zitat Hennig IM, Laissue JA, Horisberger U et al (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61:786–792CrossRefPubMed Hennig IM, Laissue JA, Horisberger U et al (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61:786–792CrossRefPubMed
15.
Zurück zum Zitat International Society for the Study of Vascular Anomalies (2014) ISSVA Classification of vascular anomalies. In: Classification. International Society for the Study of Vascular Anomalies. www.issva.org/classification. Accessed Apr 2014 International Society for the Study of Vascular Anomalies (2014) ISSVA Classification of vascular anomalies. In: Classification. International Society for the Study of Vascular Anomalies. www.​issva.​org/​classification. Accessed Apr 2014
16.
Zurück zum Zitat Jang JH, Nam TS, Paik KS et al (2004) Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumaticneuropathy model of the rat. Neurosci Lett 360:129–132CrossRefPubMed Jang JH, Nam TS, Paik KS et al (2004) Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumaticneuropathy model of the rat. Neurosci Lett 360:129–132CrossRefPubMed
17.
Zurück zum Zitat Koh YH, Tamizhselvi R, Bhatia M (2010) Extracellular signalregulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells. J Pharmacol Exp Ther 332:940–948CrossRefPubMed Koh YH, Tamizhselvi R, Bhatia M (2010) Extracellular signalregulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells. J Pharmacol Exp Ther 332:940–948CrossRefPubMed
18.
Zurück zum Zitat Lai JP, Douglas SD, Ho WZ (1998) Human lymphocytes express substance P and its receptor. J Neuroimmunol 86:80–86CrossRefPubMed Lai JP, Douglas SD, Ho WZ (1998) Human lymphocytes express substance P and its receptor. J Neuroimmunol 86:80–86CrossRefPubMed
19.
Zurück zum Zitat Linnik MD, Moskowitz MA (1989) Identification of immunoreactive substance P in human and other mammalian endothelial cells. Peptides 10:957–962CrossRefPubMed Linnik MD, Moskowitz MA (1989) Identification of immunoreactive substance P in human and other mammalian endothelial cells. Peptides 10:957–962CrossRefPubMed
20.
Zurück zum Zitat Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56:4983–4991PubMed Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56:4983–4991PubMed
21.
Zurück zum Zitat Milner P, Kirkpatrick KA, Ralevic V et al (1990) Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc Biol Sci 241:245–248CrossRefPubMed Milner P, Kirkpatrick KA, Ralevic V et al (1990) Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc Biol Sci 241:245–248CrossRefPubMed
22.
Zurück zum Zitat Muñoz M, Bernabeu-Wittel J, Coveñas R (2011) NK-1 as a melanoma target. Expert Opinion Therapeutic Targets 15:889–897CrossRef Muñoz M, Bernabeu-Wittel J, Coveñas R (2011) NK-1 as a melanoma target. Expert Opinion Therapeutic Targets 15:889–897CrossRef
23.
Zurück zum Zitat Muñoz M, Carranza A, Pavón A et al (2013) Immunolocalization of substance P and NK-1 receptor in hofbauer cells in human normal placenta. Microsc Res Tech 76:1310–1313CrossRefPubMed Muñoz M, Carranza A, Pavón A et al (2013) Immunolocalization of substance P and NK-1 receptor in hofbauer cells in human normal placenta. Microsc Res Tech 76:1310–1313CrossRefPubMed
24.
Zurück zum Zitat Muñoz M, Coveñas R (2010) A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem 17:504–516CrossRefPubMed Muñoz M, Coveñas R (2010) A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem 17:504–516CrossRefPubMed
25.
Zurück zum Zitat Muñoz M, Coveñas R (2011) NK-1 receptor antagonists: a new paradigm in pharmacological therapy. Curr Med Chem 18:1820–1831CrossRefPubMed Muñoz M, Coveñas R (2011) NK-1 receptor antagonists: a new paradigm in pharmacological therapy. Curr Med Chem 18:1820–1831CrossRefPubMed
26.
Zurück zum Zitat Muñoz M, Coveñas R (2013) Involvement of substance P and the NK-1 receptor in cancer. Peptides 48:1–9CrossRefPubMed Muñoz M, Coveñas R (2013) Involvement of substance P and the NK-1 receptor in cancer. Peptides 48:1–9CrossRefPubMed
27.
Zurück zum Zitat Muñoz M, Coveñas R, Esteban F et al (2015) The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J Biosci 40:441–463CrossRefPubMed Muñoz M, Coveñas R, Esteban F et al (2015) The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J Biosci 40:441–463CrossRefPubMed
28.
Zurück zum Zitat Muñoz M, González-Ortega A, Rosso M et al (2012) The substance P/Neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists. Peptides 38:318–325CrossRefPubMed Muñoz M, González-Ortega A, Rosso M et al (2012) The substance P/Neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists. Peptides 38:318–325CrossRefPubMed
29.
Zurück zum Zitat Muñoz M, Pavon A, Rosso M et al (2010) Immunolocalization of NK-1 receptor and substance P in human normal placenta. Placenta 31:649–651CrossRefPubMed Muñoz M, Pavon A, Rosso M et al (2010) Immunolocalization of NK-1 receptor and substance P in human normal placenta. Placenta 31:649–651CrossRefPubMed
30.
Zurück zum Zitat North PE, Waner M, Mizeracki A et al (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11–22CrossRefPubMed North PE, Waner M, Mizeracki A et al (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11–22CrossRefPubMed
31.
Zurück zum Zitat North PE, Waner M, Mizeracki A et al (2001) A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137:559–570CrossRefPubMed North PE, Waner M, Mizeracki A et al (2001) A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137:559–570CrossRefPubMed
32.
Zurück zum Zitat Samsam M, Coveñas R, Csillik B et al (2001) Depletion of substance P, neurokinin A and calcitonin gene-related peptide from the contralateral and ipsilateral caudal trigeminal nucleus following unilateral electrical stimulation of the trigeminal ganglion; A possible neurophysiological and neuroanatomical link to generalized head pain. J Chem Neuroanat 21:161–169CrossRefPubMed Samsam M, Coveñas R, Csillik B et al (2001) Depletion of substance P, neurokinin A and calcitonin gene-related peptide from the contralateral and ipsilateral caudal trigeminal nucleus following unilateral electrical stimulation of the trigeminal ganglion; A possible neurophysiological and neuroanatomical link to generalized head pain. J Chem Neuroanat 21:161–169CrossRefPubMed
33.
Zurück zum Zitat Walczak-Drzewiecka A, Ratajewski M, Wagner W et al (2008) HIF1alphais up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol 181:1665–1672CrossRefPubMed Walczak-Drzewiecka A, Ratajewski M, Wagner W et al (2008) HIF1alphais up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol 181:1665–1672CrossRefPubMed
34.
Zurück zum Zitat Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:203–214CrossRef Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:203–214CrossRef
35.
Zurück zum Zitat Ziche M, Morbidelli L, Pacini M et al (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40:264–278CrossRefPubMed Ziche M, Morbidelli L, Pacini M et al (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40:264–278CrossRefPubMed
36.
Zurück zum Zitat Ziche M, Morbidelli L, Pacini M et al (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036–2044CrossRefPubMedPubMedCentral Ziche M, Morbidelli L, Pacini M et al (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036–2044CrossRefPubMedPubMedCentral
Metadaten
Titel
Immunolocalization of substance P and NK-1 receptor in vascular anomalies
verfasst von
Alejandro Ortiz-Prieto
José Bernabeu-Wittel
Teresa Zulueta-Dorado
Ana I. Lorente-Lavirgen
Miguel Muñoz
Publikationsdatum
17.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 2/2017
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1707-y

Weitere Artikel der Ausgabe 2/2017

Archives of Dermatological Research 2/2017 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.